Adocia reports positive preliminary results for first clinical trial of BioChaperone Combo
Adocia announces today positive preliminary results for the first clinical trial on an innovative formulation combining insulin analog Glargine (Lantus, Sanofi), the gold standard basal insulin, with a rapid-acting insulin analog, Lispro (Humalog, Eli Lilly) using Adocia’s BioChaperone technology. …read more
